What is NVST's market cap?

$4.01B, based on the Nov 6 close of $25.03.

What is NVST's P/E ratio?

42.2× trailing-twelve-month earnings of $95M.

How much of NVST is sold short?

9.8M shares, 6.1% of float, as of Oct 15, 2026.

What sector is NVST in?

Healthcare, in the Dental Equipment industry.

NYSE · NVSTHealthcareDental Equipment

Envista Holdings Corporation Common stock, $0.01 par value per share (NVST)

$25.03+0.28%

Close Nov 6, 2026 · split-adjusted

Nov 5, 2026$24.86▲ 23.37% in range

Nov 4, 2025Low $18.95 · High $30.26Nov 5, 2026

What changed · written from our data

As of Nov 6, 2026

Envista Holdings Corporation Common stock, $0.01 par value per share closed at $25.03 on Nov 6, up 0.28%, 17.3% below its 52-week closing high. Volume of 1.2M shares was 0.35× its 20-day average (below normal).

Split-adjusted performance: +10.2% over one month, +3.3% over six months, +24.2% over one year.

In the quarter ended Jul 3, 2026, revenue was $730.50M, up 7.1% from a year earlier, with a net margin of 7.4%.

Short interest was 9.8M shares at the Oct 15 settlement, down 19.0% from the prior report (6.1% of float, 4.1 days to cover).

Market cap$4.01B160.3M shares

Revenue · quarter$730.5M+7.1% YoY

Diluted EPS$0.33+106.3% YoY

P/E · TTM42.2×P/S 1.4×

Net margin7.4%Gross 55.7%

Dividend yieldNone

52-week range18.95 – 30.26−17.3% from high

Volume1.2M0.35× 20-day avg

Volatility · 60d39.1%Annualised

Short % of float6.1%4.1 days to cover

Net cash-$310.7MCash $1.13B

Next earnings—Not scheduled

Split-adjusted performance

1W +6.5%1M +10.2%3M −11.2%6M +3.3%YTD +15.3%1Y +24.2%3Y +8.9%5Y −36.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Dental Equipment

Percentile among 2 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −4.9%, revenue growth +1.5%, net margin 5.7%, P/E 42.2×.

Short interest

Details →

Shares short9.8M−19.0% vs prior

Days to cover4.1Settled Oct 15

% of float6.1%

Short vol. 10d52.4%of daily volume

Closest peers by size in Dental Equipment

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share	$25.03	+0.28%	+3.3%	+7.1%	7.4%	42.2	$4.01B
XRAYDENTSPLY SIRONA	$9.56	−5.30%	−13.1%	−4.1%	4.1%	—	$1.90B	Compare

News about Envista Holdings Corporation Common stock, $0.01 par value per share

All news →

Envista (NVST) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research · 2d ago▲ Positive Envista (NVST) Tops Q3 Earnings and Revenue EstimatesZacks Investment Research · 2d agoNeutral Envista Q3 Earnings Ahead: Product Innovation to Drive GrowthZacks Investment Research · Oct 28, 2026Neutral Envista (NVST) Earnings Expected to Grow: Should You Buy?Zacks Investment Research · Oct 28, 2026▼ Negative Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research · Oct 9, 2026Neutral

Quick answers

What does Envista Holdings Corporation Common stock, $0.01 par value per share do?: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals.
What is NVST's market cap?: $4.01B, based on the Nov 6 close of $25.03.
What is NVST's P/E ratio?: 42.2× trailing-twelve-month earnings of $95M.
Does Envista Holdings Corporation Common stock, $0.01 par value per share pay a dividend?: No regular cash dividend has been paid in the last year.
How much of NVST is sold short?: 9.8M shares, 6.1% of float, as of Oct 15, 2026.
What sector is NVST in?: Healthcare, in the Dental Equipment industry.

About Envista Holdings Corporation Common stock, $0.01 par value per share

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

HQ: Brea, CA12,000 employeesListed Sep 18, 2019envistaco.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology